{"id":839069,"date":"2025-04-18T08:03:36","date_gmt":"2025-04-18T12:03:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/"},"modified":"2025-04-18T08:03:36","modified_gmt":"2025-04-18T12:03:36","slug":"eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/","title":{"rendered":"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue"},"content":{"rendered":"

<\/p>\n

Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue<\/strong><\/p>\n

CAIRO–(BUSINESS WIRE<\/a>)–
\nEdwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly improved long-term outcomes compared to those receiving non-RESILIA tissue bioprosthetic valves.\n<\/p>\n

\nFor more than 65 years, Edwards has been the leader in heart valve innovations. To create a more durable heart valve, Edwards developed the RESILIA tissue technology more than two decades ago. Today, RESILIA tissue is used in a wide range of Edwards\u2019 surgical and transcatheter platforms, including the INSPIRIS RESILIA aortic surgical valve, the KONECT RESILIA aortic surgical valve conduit, the MITRIS RESILIA mitral surgical valve and the SAPIEN 3 Ultra RESILIA transcatheter aortic heart valve. Edwards\u2019 INSPIRIS RESILIA and SAPIEN 3 Ultra RESILIA valves are supported by extensive, long-term clinical evidence which is the result of three decades of innovation and expertise, leveraging the proven Carpentier-Edwards PERIMOUNT platform.\n<\/p>\n

\n\u201cThese highly anticipated data provide strong clinical evidence of the excellent durability of RESILIA tissue in surgical valves,\u201d said Tsuyoshi Kaneko, M.D., John M. Shoenberg Chair of Cardiovascular Disease, Chief of Cardiac Surgery at Washington University in St. Louis and lead author of the study. \u201cThis level of performance is critical to reducing reinterventions and enabling more effective lifetime management for patients.\u201d\n<\/p>\n

\nPresented at the Heart Valve Society Annual Meeting, the study of 947 patients marks the first long-term, propensity-matched comparison between RESILIA tissue and non-RESILIA tissue surgical aortic valves. The RESILIA tissue data from the trial reported encouraging results through eight years, with low rates of structural valve deterioration (99.3% freedom from SVD in the RESILIA tissue group versus 90.5% in the non-RESILIA tissue group, p<0.0001) and freedom from reoperation due to SVD (99.2% in the RESILIA tissue group versus 93.9% in the non-RESILIA tissue group, p=0.0007).\n<\/p>\n

\n\u201cThese data further validate the growing body of scientific evidence supporting the long-term durability, performance and significant patient benefits of our proprietary RESILIA tissue,\u201d said Wayne Markowitz, Edwards\u2019 senior vice president, surgical structural heart.\n<\/p>\n

\nTo date, more than 450,000 patients worldwide have been treated with Edwards\u2019 surgical or TAVR valves with RESILIA tissue, reflecting its expanding role in the treatment of structural heart disease.\n<\/p>\n

\n\u201cWith patients of all ages living longer and demanding higher quality of life, the importance of lifetime management has never been greater,\u201d said Larry Wood, Edwards\u2019 corporate vice president and group president, transcatheter aortic valve replacement and surgical structural heart. \u201cThis significant advancement in tissue technology highlights Edwards\u2019 dedication to pioneering unique innovations and improving patient outcomes.\u201d\n<\/p>\n

About Edwards Lifesciences<\/b><\/p>\n

\nEdwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com<\/a> and follow us on LinkedIn<\/a>, Facebook<\/a>, Instagram<\/a> and YouTube<\/a>.\n<\/p>\n

\nThis news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend the forward-looking statements contained in this release to be covered by the safe harbor provisions of such Acts. These forward-looking statements can sometimes be identified by the use of forward-looking words, such as \u201cmay,\u201d \u201cmight,\u201d \u201cbelieve,\u201d \u201cwill,\u201d \u201cexpect,\u201d \u201cproject,\u201d \u201cestimate,\u201d \u201cshould,\u201d \u201canticipate,\u201d \u201cplan,\u201d \u201cgoal,\u201d \u201ccontinue,\u201d \u201cseek,\u201d \u201cintend,\u201d \u201coptimistic,\u201d \u201caspire,\u201d \u201cconfident\u201d and other forms of these words and include, but are not limited to, statements made by Messrs. Wood and Markowitz and statements regarding expected long-term patient benefits, clinical outcomes, objectives, and expectations and other statements that are not historical facts. Forward-looking statements are based on estimates and assumptions made by management of the company and are believed to be reasonable, though they are inherently uncertain and difficult to predict. Our forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. Investors are cautioned not to unduly rely on such forward-looking statements.\n<\/p>\n

\nForward-looking statements involve risks and uncertainties that could cause results to differ materially from those expressed or implied by the forward-looking statements based on a number of factors as detailed in the company’s filings with the Securities and Exchange Commission. These filings, along with important safety information about our products, may be found at Edwards.com.\n<\/p>\n

\nEdwards, Edwards Lifesciences, the stylized E logo, Carpentier-Edwards, INSPIRIS, INSPIRIS RESILIA, KONECT, KONECT RESILIA, MITRIS, MITRIS RESILIA, PERIMOUNT, RESILIA, SAPIEN, SAPIEN 3, and SAPIEN 3 Ultra are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250418069216\/en\/<\/a><\/span><\/p>\n

\nMedia Contact: Amy Meshulam, 949-250-4009
\n
Investor Contact: Mark Wilterding, 949-250-6826\n<\/p>\n

KEYWORDS:<\/b> Africa Egypt<\/p>\n

INDUSTRY KEYWORDS:<\/b> Medical Devices Health Surgery Health Technology Clinical Trials Cardiology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue CAIRO–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly improved long-term outcomes compared to those receiving non-RESILIA tissue bioprosthetic valves. For more than 65 years, Edwards has been the leader in heart valve innovations. To create a more durable heart valve, Edwards developed the RESILIA tissue technology more than two decades ago. Today, RESILIA tissue is used in a wide range of Edwards\u2019 surgical and transcatheter platforms, including the INSPIRIS RESILIA aortic surgical valve, the KONECT RESILIA aortic surgical valve conduit, the MITRIS RESILIA mitral surgical valve and the SAPIEN 3 Ultra RESILIA … <\/p>\n

Continue reading “Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-839069","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue CAIRO–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly improved long-term outcomes compared to those receiving non-RESILIA tissue bioprosthetic valves. For more than 65 years, Edwards has been the leader in heart valve innovations. To create a more durable heart valve, Edwards developed the RESILIA tissue technology more than two decades ago. Today, RESILIA tissue is used in a wide range of Edwards\u2019 surgical and transcatheter platforms, including the INSPIRIS RESILIA aortic surgical valve, the KONECT RESILIA aortic surgical valve conduit, the MITRIS RESILIA mitral surgical valve and the SAPIEN 3 Ultra RESILIA … Continue reading "Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-18T12:03:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250418069216r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue\",\"datePublished\":\"2025-04-18T12:03:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/\"},\"wordCount\":832,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250418069216r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/\",\"name\":\"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250418069216r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-04-18T12:03:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250418069216r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250418069216r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/","og_locale":"en_US","og_type":"article","og_title":"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue - Market Newsdesk","og_description":"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue CAIRO–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly improved long-term outcomes compared to those receiving non-RESILIA tissue bioprosthetic valves. For more than 65 years, Edwards has been the leader in heart valve innovations. To create a more durable heart valve, Edwards developed the RESILIA tissue technology more than two decades ago. Today, RESILIA tissue is used in a wide range of Edwards\u2019 surgical and transcatheter platforms, including the INSPIRIS RESILIA aortic surgical valve, the KONECT RESILIA aortic surgical valve conduit, the MITRIS RESILIA mitral surgical valve and the SAPIEN 3 Ultra RESILIA … Continue reading \"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-18T12:03:36+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250418069216r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue","datePublished":"2025-04-18T12:03:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/"},"wordCount":832,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250418069216r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/","name":"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250418069216r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-04-18T12:03:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250418069216r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250418069216r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eight-year-data-confirm-long-term-durability-of-edwards-resilia-tissue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Eight-Year Data Confirm Long-Term Durability of Edwards\u2019 RESILIA Tissue"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=839069"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839069\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=839069"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=839069"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=839069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}